This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Review of Incidence Studies of Tardive Dyskinesia Associated With Typical Antipsychotics

William M. Glazer, MD

Published: April 30, 2000

Article Abstract

Unless researchers make an organized effort, patients with tardive dyskinesia are difficult to studyand easily lost to follow up. Because there is no treatment for tardive dyskinesia, investigators areobliged to study the natural history of the disorder and identify risk and prognostic factors to furtherunderstand pathophysiologic mechanisms and to guide prevention and treatment efforts. Abundantvariability exists among incidence studies of tardive dyskinesia, depending to some extent on designissues. In this article, the design concepts of incidence and prevalence studies are described, alongwith results, methodological problems, and identified risk factors in various tardive dyskinesia incidencestudies involving the use of typical antipsychotic medications.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...